Table 3.
Multivariate Cox proportional hazards analyses of beta-hCG, CA19-9, CA125, CEA on overall survival and recurrence free survival.
| Variables | Recurrence free survival | Overall survival | ||
|---|---|---|---|---|
| HR (95%Cl) | P value | HR (95%Cl) | P value | |
| Age | 1.01 (0.98-1.04) | 0.569 | 0.98 (0.96-1.01) | 0.152 |
| Male | 0.68 (0.34-1.45) | 0.099 | 0.78 (0.43-1.46) | 0.420 |
| ASA 3-4 | 0.85(0.20-2.54) | 0.791 | 0.63 (0.18-1.69) | 0.630 |
| hCG >5 | 4.51 (1.49-12.41) | 0.005 | 3.88 (1.43-10.25) | 0.006 |
| CA19-9 >37 | 2.27 (0.08-5.66) | 0.095 | 2.14 (0.89-4.82) | 0.074 |
| CA125 >35 | 4.15 (1.39-11.24) | 0.007 | 6.21 (1.34-32.16) | 0.019 |
| CEA >20 | 3.31 (0.46-15.95) | 0.161 | 1.63 (0.51-4.43) | 0.367 |
| pT3-4 | 3.73 (1.92-7.50) | <0.001 | 4.23 (2.45-7.43) | <0.001 |
| pN1-3 | 1.99 (0.90-4.13) | 0.043 | 4.56 (2.49-8.31) | <0.001 |
| Adjuvant chemotherapy | 1.60 (0.68-3.44) | 0.248 | 3.19 (1.70-5.89) | 0.550 |